Lacar, Elmer B.
HRN: 23-79-80 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/09/2023
CEFUROXIME 1.5GM (VIAL)
10/09/2023
10/15/2023
IV
1.5gm
Q8
Thyroglossal Duct Cyst
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Overall appropriateness: Yes